Skip to main content
Table of Contents
Print

Does Cannabis Use Enhance or Reduce Therapy Success Rates for Panic Disorder? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

The role of cannabis in therapy for panic disorder  is increasingly explored. Understanding cannabis therapy outcomes for panic can inform both patients and clinicians about potential benefits and limitations in treatment plans. 

Impact on Therapy Success 

Evaluating cannabis therapy outcomes for panic helps determine whether it supports or hinders treatment effectiveness. 

Treatment Effectiveness 

Treatment effectiveness may be influenced by cannabis use, with some studies suggesting moderate use can reduce acute anxiety and support engagement in therapy sessions. 

Therapy Augmentation 

Cannabis could serve as a therapy augmentation tool, potentially easing emotional barriers and facilitating exposure-based exercises. 

Clinical Evidence 

Existing clinical evidence on cannabis therapy outcomes for panic remains limited, highlighting the need for careful assessment and personalised treatment planning. 

Monitoring Progress 

Monitoring both patient response and therapy adherence ensures cannabis therapy outcomes for panic are optimised without compromising safety. 

Cannabis therapy outcomes for panic vary depending on dosage, timing, and individual sensitivity. While therapy augmentation may improve session engagement, reliance on cannabis should be balanced to maintain treatment effectiveness and align with best clinical evidence. 

If you’re exploring cannabis treatment options for panic disorder, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Panic Disorder . 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories